It was FDA approved based on a clinical trial that showed it, overall, delayed the onset of insulin dependence from two years ...

Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...

UK chart-topper Phil Collins has seemingly pulled down the curtain on his long career, saying he has no wish to make any further music. The former Genesis frontman and solo superstar, now 74, told ...

REPORT Happy Friday! This weekend is daylight saving time, I’d tell you to change your clocks but I’m guessing most of us ...

The second reason I highlight is Eli Lilly's Mounjaro, which is actively increasing its share in the type 2 diabetes treatment ... However, if you look at the chart below, this implies a ...

The GLP-1 industry is currently an oligopoly ruled by two pharmaceutical giants, Novo Nordisk A/S (NYSE: NVO), maker of ...

Emergen Research Logo The global Generic Drug Market size was USD 360.84 Billion in 2022 and is expected to register a rapid revenue CAGR o ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Also: Warnings from the stock and real-estate markets; Eli Lilly’s success; a mixed response to Nvidia; and how cuts to ...

The stock market offers numerous opportunities for building wealth, especially when the right equities are involved.

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. Let's figure out ...